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The inherent cytotoxicity of aberrantly folded protein
aggregates contributes substantially to the patho-
genesis of amyloid diseases. It was recently shown
that a classof evolutionary conservedproteins, called
MOAG-4/SERF, profoundly alter amyloid toxicity via
an autonomous but yet unexplained mode. We
show that the biological function of human SERF1a
originates from its atypical ability to specifically
distinguish between amyloid and nonamyloid aggre-
gation. This inherently unstructured protein directly
affected the aggregation kinetics of a broad range of
amyloidogenic proteins in vitro, while being inactive
against nonamyloid aggregation. A representative
biophysical analysis of the SERF1a:a-synuclein
(aSyn) complex revealed that the amyloid-promoting
activity resulted from an early and transient interac-
tion, which was sufficient to provoke a massive
increase of soluble aSyn amyloid nucleation tem-
plates. Therefore, the autonomous amyloid-modi-
fying activity of SERF1a observed in living organisms
relies on a direct and dedicated manipulation of the
early stages in the amyloid aggregation pathway.
INTRODUCTION
Amyloidogenic proteins are a class of polypeptides capable of
assembling into insoluble fibers with a distinct cross beta-sheet
structure (Eichner and Radford, 2011). Amyloids are under inten-
sive scientific investigation because of their association with
a series of highly prevalent and incurable neurodegenerative
disorders, including Parkinson’s disease, Alzheimer’s disease,358 Cell Reports 2, 358–371, August 30, 2012 ª2012 The AuthorsHuntington’s disease, and prion-related encephalopathies (Chiti
and Dobson, 2006). In degenerating neurons, amyloid fibers can
occur as either intracellular or extracellular deposits, which are
positive to the dyes Congo Red and Thioflavin T.
Themultifactorial nature of these neurodegenerative disorders
complicates efforts to clearly define a link between oligomers,
fibers, and disease. It has been proposed that structurally unre-
lated amyloid proteins undergo similar structural rearrangements
on their way to becoming mature amyloids and that the toxic
species consist of intermediate protein aggregates (Glabe, 2006).
To identify cofactors that modulate intracellular amyloid
formation, a genetic screen was performed and led to the
discovery of MOAG-4/SERF (Modifier of aggregation-4/Small
EDRK rich factor) as an evolutionary conserved class of
amyloid-regulating proteins (van Ham et al., 2010). Knockdown
of MOAG-4/SERF expression in eukaryotic cells suppressed
aggregation of huntingtin (htt), a-synuclein (aSyn), and beta-
amyloid (Ab). This effect appears unrelated to other traditional
aggregation-modifying pathways, such as the chaperone-
folding machinery, proteasomal degradation, or autophagy,
because their manipulation did not alter the activity of MOAG-
4/SERF. However, the exact mechanism by which MOAG/
SERF promotes amyloid formation remained unsolved.
To resolve this important issue, we explored the possibility that
MOAG-4/SERF drives aggregation through a direct interaction
with aggregation-prone disease proteins. To this end, we tested
the effect of human SERF1a (short isoform) in an isolated in vitro
system on a set of structurally unrelated amyloidogenic proteins.
RESULTS
SERF1a Accelerates a-Synuclein Amyloidogenesis
SERF1a is a basic (pI = 10.44), 7.4 kDa protein. A structural
analysis identified the recombinant molecule as predominantly
disordered (Figure 1).
To look for a direct influence of SERF1a on the amyloid
assembly, we measured the time-dependent amyloid conver-
sion of the Parkinson’s disease-associated protein aSyn, which
aggregates into Lewy bodies (Spillantini et al., 1998). Monomeric
aSyn was incubated in the absence or presence of SERF1a and
amyloid formation was monitored by Thioflavin T (ThT) fluores-
cence. ThT exhibits a fluorescence emission maximum at
488 nm exclusively when bound to amyloid (LeVine, 1999). In
the absence of SERF1a, aSyn converted into amyloid fibers
with a half time of conversion tm = 50 hr, and an initial lag phase
tl = 21 hr (Figure 2A and Table 1). Equimolar amounts of SERF1a
accelerated half time of conversion to tm = 13 hr, and the lag
phase was reduced by approximately 50% (tl = 10 hr). This
caused a significant accumulation of ThT-reactive species, as
indicated by the higher (approximately 4-fold) ThT fluorescence
intensity as compared to aSyn alone.
We could exclude that SERF1a might itself assemble into
amyloid fibrils, as it was not reactive to ThT (Figure 2), even after
several months of incubation at high concentrations (10 mM;
data not shown). In addition, dot-blot partition analysis coupled
to immunodetection showed that SERF1a remained in solution
(Figure 2B, lower), whereas the aSyn amyloid fibers, as ex-
pected, partitioned into the insoluble fraction (Figure 2B, upper).
SDS-PAGE analysis of the same samples showed that SERF1a
did not incorporate into stable SDS-resistant oligomers (Fig-
ure S1A), which are typical for amyloid fiber intermediates
(Bagriantsev et al., 2006). Finally, we excluded the possibility
of heterogeneous cross-seeding (Yagi et al., 2005), as preformed
aSyn nucleation seeds did not cause the formation of SERF1a
fibers (Figure S1B).
These results indicated that SERF1a was able to directly
influence aSyn amyloid fiber assembly without becoming
incorporated into the amyloid fibers. To determine the specificity
of this effect we tested two control proteins TraMDN from
Escherichia coli and hsp12 from Saccharomyces cerevisiae.
TraMDN represents the globular, 8.1 kDa C-terminal domain
(aa 57–127) of a bacterial conjugation component (Lu et al.,
2008), whereas hsp12 is a 11.7 kDa intrinsically disordered
heat shock protein without any aggregation-modifying activity
(Welker et al., 2010). TraMDN or hsp12 did not significantly alter
aSyn amyloid growth (Figures 2C and 2D).
SERF1a Discriminates between Amyloid
and Nonamyloid Aggregation
To address whether SERF1a is active on other amyloidogenic
proteins, we tested its effect on human huntingtin (htt Ex1Q53;
htt gene exon 1 with a 53 glutamine repeat sequence), human
Ab40, and full-length mouse prion protein (PrP), which are
related to Huntington’s disease, Alzheimer’s disease, and trans-
missible spongiform encephalopathies (prion diseases), respec-
tively (Chiti and Dobson, 2006). In all cases, the addition of
SERF1a decreased the initial lag phase of amyloid growth and
accelerated the half time of conversion, thus favoring the gener-
ation of ThT-reactive species (Figures 2E–2G and Table 1).
Therefore, SERF1a is active on a broad range of structurally
diverse proteins/peptides, suggesting that this protein is a
specialized amyloid-promoting factor. This is supported by
SERF1a being inactive to different nonamyloid aggregationprocesses. First, this protein was unable to rescue ‘‘off-amyloid
pathway’’ aggregates. These are stable, alternatively folded olig-
omers, which are nonamyloidogenic and do not grow into
mature fibers (Cappai et al., 2005; Ehrnhoefer et al., 2008;
Pham et al., 2009). SERF1a failed to process representative
dopamine-induced ‘‘off-pathway’’ aSyn oligomers (Cappai
et al., 2005; Phamet al., 2009) (isolated as described in Figure S2)
into amyloid fibers or to disassemble them into monomers
(Figures 3A–3C).
Second, SERF1a did not influence the organized assembly of
nonamyloid filaments, as it failed to affect the conversion of
F-actin into G-actin (Figure 3D), despite both amyloid and actin
polymerization imply nucleation, elongation, and maturation
(Morris et al., 2009).
Third, SERF1a did not promote nonspecific aggregation, as
shown for two conventional aggregation models. Turbidity
measurements indicated that the addition of SERF1a did not
alter the aggregation profile of citrate synthase (Buchner et al.,
1998) (Figure 3E) and insulin (Scheibel et al., 1998) (Figure 3F).
This also implied that SERF1a is not acting as a molecular chap-
erone, which is a protein class able to suppress nonspecific
protein aggregation (Hartl et al., 2011).
These results all suggest that SERF1a has the atypical ability
to specifically distinguish between amyloid and nonamyloid
aggregation.
SERF1a Promotes the Generation of ‘‘On-Pathway’’
Aggregates
We analyzed the SERF1a-driven amyloid aggregation in more
detail. We restricted our investigation to aSyn as a representative
interaction partner, as this protein has a well-characterized
mechanism of amyloidogenesis (Bertoncini et al., 2005; Dedmon
et al., 2005; Ferna´ndez et al., 2004; Ullman et al., 2011). The
interaction between SERF1a and aSyn caused a massive
increase in soluble, high molecular weight aggregates. A size-
exclusion chromatographic analysis showed that this type of
aggregates was not detectable in the absence of SERF1a (Fig-
ure 4A). The aggregates were kinetically unstable and disap-
peared after a prolonged reaction time (3–4 days). Yet, after
approximately 30 hr, they were sufficiently abundant and stable
for their isolation (Figure S3). They consisted exclusively of
ThT-reactive aSyn species (Figure S3B), and SERF1a did not
coelute with them (Figures S3C and S3D), indicating that it did
not stably associate with aggregating aSyn. Moreover, SERF1a
did not bind to mature fibrils, as it barely colocalized into the
insoluble fraction containing the aSyn aggregates (Figure 2B,
lower, and Figure S1A). This is consistent with cellular studies
attesting that the C. elegans ortholog MOAG-4 is excluded
from the amyloid aggregates (van Ham et al., 2010).
The isolated aggregates acted as dose-dependent nucleation
templates (‘‘on-pathway’’ aggregates), because the conversion
of monomeric aSyn into amyloid was significantly enhanced as
the SERF1a:aSyn ratio was increased, and the initial lag phase
was visibly reduced (Figure 4B). Transmission electron micro-
graphs identified these aggregates as single dots and short-
sized rods with a maximal length of 400 nm (Figure 4C). They
were by far shorter than the tangles of mature amyloid fibrils
(R1 mM, Figure 4D), yet ThT-reactive (Figure S3B), andCell Reports 2, 358–371, August 30, 2012 ª2012 The Authors 359
Figure 1. SERF1a Is Predominantly Disordered
(A) An 1H,15N-HSQC NMR spectrum of 100 mM SERF1a shows little signal dispersion of the proton peaks, with each signal located within a narrow proton range
between 7.8 and 8.7 ppm. Such a distribution is typical for flexible proteins with low secondary structural contents (Tompa, 2010).
(B) The far-UV CD-spectrum of SERF1a (solid blue line) recorded between 190 and 240 nm, lacked any predominant alpha helix (minima at 222 and 208 nm) or
beta sheet (minimum at 216 nm) signal. Instead, the curve was dominated by a strong negative signal around 200 nm and by a slow positive signal recovery below
200 nm. This is indicative for the predominance of conformational disorder (Tompa, 2010). The presence of a residual secondary structure was deducible by its
disruption upon the addition of the chaotropic agent urea (dashed red line), which resulted in a positive signal shift (spectrum collected up to 210 nm because of
the interfering strong background signal of the denaturant below this value). This was also reflected by secondary structural deconvolution analysis of the CD
spectrum (Whitmore and Wallace, 2008; Sreerama et al., 1999), which yielded a predominant 76.8% random coil contents, and a residual 17.8% alpha helix and
6.2% beta sheet structure.
(C) These results were supported by dynamic light scattering (C), which provides the hydrodynamic radii of particles in solution. The measured mean radius for
SERF1a was 2.08 nm (solid blue line), whereas globular proteins of similar molecular size possess much smaller Rh values (around 1.5 nm) (Uversky, 1993). In the
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predominantly beta-sheet structured (Figure 4E), thus displaying
peculiarities of elongating amyloid fibers. Their morphology was
also completely different from that of the dopamine-stabilized
‘‘dead-end’’ aggregates (Figure 3B), which instead formed small
spheres with a diameter of approximately 20 nm.
Such a measurable accumulation of transient ‘‘on-pathway’’
aggregates is significant, because these species are usually
not abundant owing to their rapid conversion into mature fibers
(Kim et al., 2009; Lashuel et al., 2002) and are therefore hard to
capture.
This data led us to propose that the interaction between
SERF1a and aSyn was transiently restricted to the initial stages
of amyloidogenesis, serving to accelerate the generation of
active, elongating amyloid intermediates (‘‘on-pathway’’ aggre-
gates), which drive the amyloid reaction as they are incorporated
into the growing fibrils. Such an early effect was supported by
SERF1a showing little influence on seeded (Figure 2I) compared
to nonseeded amyloid growth (Figure 2A), suggesting a mode of
action which preceded the preamyloid nucleation phase. This
was reinforced by the ability of substoichiometric levels of
SERF1a to still promote amyloidogenesis (Figure 2H), in support
of a transient rather than a stable stoichiometric association. This
finding is consistent with the effect of MOAG-4 on polyglutamine
aggregation in cells (van Ham et al., 2010).
SERF1a Interacts with the C Terminus of a-Synuclein
To define more accurately the details of this early and transient
relationship, we investigated the mode of interaction between
SERF1a and monomeric aSyn. We used 1H, 15N-HSQC NMR
(heteronuclear single quantum coherence nuclear magnetic
resonance) spectroscopy, because aSyn has been extensively
studied by this technique (Chandra et al., 2003; Ferna´ndez
et al., 2004; Rasia et al., 2005; Wang et al., 2011). The stepwise
addition of SERF1a to a uniformly 15N-labeled monomeric aSyn
sample caused substantial and saturable shift perturbations of
the amino acid backbone signals located between C-terminal
aSyn residues Gly111 and Ala140 (Figure 5A and Figure S4).
Binding curves obtained from chemical shift titrations of the
twowell-resolved amino acids Asp122 andSer129 yielded a disso-
ciation constant for the interaction KD7–10 mM (Figure 5B). This
indicated that the interaction with SERF1a was localized to the
acidic C-terminal region of aSyn.
This bindingmodewas supported by fluorescence anisotropy,
a technique that can measure changes in the rotational mobility
of a fluorophore covalently attached to a protein upon complex
formation (Lakowicz, 1999). The titration of site-specific fluores-
cence-labeled SERF1a with unlabeled full-length aSyn, led to
a saturable increase of the anisotropy value r (Figure 5C). The
resulting binding curve yielded KD = 8.04 ± 2.09 mM, in good
agreement to the value previously obtained by NMR spectros-presence of urea, Rh shifted to 3.16 nm (dashed red line), implying that, despite t
completely disrupted by this chaotrope.
(D) Small-angle X-ray scattering, a technique that measures the size and shape of
plot of SERF1a increased monotonally without any detectable maximum (solid bl
(Tompa, 2010). In contrast, a well-defined maximum could be detected for the re
(E) Primary structure of SERF1a (UniProt accession number O75920-2).copy (Figure 5B). In contrast, the interaction was substantially
altered for aSyn1-110, a truncation mutant lacking Gly111-
Ala140, and binding to this mutant was no longer saturable
(extrapolated KD value >1 mM) (Figure 5C).
According to current mechanistic models of aSyn amyloido-
genesis, generic perturbations of the C-terminal region can
expose the otherwise more protected amyloid core region,
thereby promoting fibril formation (Bertoncini et al., 2005;
Dedmon et al., 2005; Hoyer et al., 2004; Levitan et al., 2011;
McClendon et al., 2009; Murray et al., 2003). This effect has
been previously observed for charged ligands, such as metal
ions or polyamines (Ferna´ndez et al., 2004; Nielsen et al.,
2001; Rasia et al., 2005). They all bound to the C-terminal region
(yet with a much weaker binding affinity than SERF1a: KD 7–
10 mM for SERF1a versus several hundred micromolar for the
other ligands) and thereby affected aSyn aggregation. We deter-
mined if this also applied to SERF1a and found that this protein
was no longer able to influence fiber growth of the C-terminal
truncation mutant aSyn1110 (Figure 5D), which is in clear-cut
contrast to full-length aSyn (Figure 2A). Thus, there existed
a clear relationship between the amyloid-modifying activity of
SERF1a and its binding to the C-terminal region of aSyn.
Based on these results, we have set up a model (Figure 6)
wherein SERF1a promotes aSyn amyloid growth by directly
interacting with the C-terminal region of the monomeric protein
(Figure 6A). Such an early mode of action precedes the preamy-
loid nucleation phase (Figure 6B). Consequently, SERF1a
promotes the ‘‘on-pathway’’ transition from a lag phase (Fig-
ure 6C) to amyloid fiber elongation (Figure 6D) and finally to
mature amyloids (Figure 6E), while disfavoring ‘‘off-pathway’’
aggregation (Figure 6F).
DISCUSSION
Our results provide clear evidence that the amyloid-promoting
activity of SERF1a is driven by a transient and selective interac-
tion with early precursors in the amyloid pathway. The selectivity
of SERF1a for amyloid aggregation distinguishes this protein
from other general modifiers of protein aggregation and explains
the unique chaperone-, proteasome-, and autophagy-indepen-
dent properties of the SERF proteins observed in cellular
systems (van Ham et al., 2010).
According to our model, SERF1a binds transiently to the
C-terminal region of aSyn. Perturbations within this region are re-
ported to cause a stable exposure of the amyloid core, which is
located in the middle region of the protein and is otherwise pro-
tected by intramolecular long-range interactions (Bertoncini
et al., 2005; Dedmon et al., 2005; Hoyer et al., 2004; Levitan
et al., 2011; McClendon et al., 2009; Murray et al., 2003). As
a consequence, aSyn amyloid precursors can generate.he lack of globularity, some residual structure was still present and that it was
a polymer, underscored the predominance of structural disorder (D). The Kratky
ue line), as expected for a macromolecule devoid of any well-defined structure
presentative globular protein lysozyme (dashed green line).
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Figure 2. Amyloid-Promoting Properties of SERF1a
(A) ThT-monitored amyloid kinetics of aSyn in the absence (closed blue circle) and in the presence of SERF1a (open green circle).
(B) Dot-blot partition analysis/immunodetection of aSyn and SERF1a in sample aliquots drawn during the aSyn amyloid growth reaction. Upper (detection of
aSyn): In the presence of equimolar amounts of SERF1a, the formation of unsoluble fibers was accelerated and after 48 hr aSyn relocated almost quantitatively
from the soluble (s) into the unsoluble (u) fraction. In the absence of SERF1a, the formation of unsoluble aSyn species was slower. An amount of soluble aSyn was
362 Cell Reports 2, 358–371, August 30, 2012 ª2012 The Authors
Table 1. Amyloid Growth Parameters
Protein SERF1a tm tl kapp
aSyn  50.51 ± 3.19 hr 21.94 ± 7.57 hr 0.07 ± 0.014 hr1
+ 13.5 ± 1.37 hr 10.94 ± 3.50 hr 0.39 ± 0.076 hr1
httQ53Ex1  81.00 ± 0.04 min 20.35 ± 0.06 min 0.036 ± 3.09 3 105 min1
+ 56.27 ± 0.35 min 9.76 ± 0.42 min 0.043 ± 2.96 3 104 min1
Ab40  12.99 ± 2.73 hr 11.35 ± 5.97 hr 0.28 ± 0.08 hr1
+ 1.58 ± 0.133 hr 0.47 ± 0.169 hr 1.79 ± 0.14 hr1
PrP  10.89 ± 0.13 hr 8.33 ± 0.88 hr 0.78 ± 0.07 hr1
+ 3.70 ± 0.13 hr 1.99 ± 0.47 hr 1.17 ± 0.2 hr1
Amyloid growth kinetic parameters for proteins used in this study in the absence and in the presence of SERF1a: midpoint of amyloid growth, tm; initial
lag phase, tl; apparent rate of amyloid formation, kapp. The values are mean averages, including the SEM of three independent measurements.The C-terminal region is composed predominantly of polar
and negatively charged amino acids and is therefore a reason-
able interaction target for a positively charged protein, such as
SERF1a (pI = 10.44). In accordance, a higher ionic strength
(300 mM) abolishes this interaction. Other positively charged
ligands, such as polyamines and divalent cations, bind to this
region as well, but by orders of magnitude weaker than SERF1a
(Ferna´ndez et al., 2004; Nielsen et al., 2001), in support of a more
specific role of the latter.
The direct interaction of SERF1a with the C-terminal region of
aSyn causes a massive increase in nucleation-active amyloid
intermediates. Given that aggregating aSyn no longer interacts
with SERF1a, we suppose that this initial short-lived association
is sufficient to lower the thermodynamic barriers of amyloid tran-
sition by reducing the lag phase and thus leading to an earlier
elongation phase. This is shown by the massive increase of
‘‘on-pathway’’ amyloid intermediates, which are able to autocat-
alytically assemble into mature fibers. We therefore propose that
SERF1a directly affects aSyn amyloidogenesis by catalyzing the
transition into amyloid-nucleating species, away fromconcurring
‘‘dead-end’’ folding events.
The general validity of this particular charge-driven interaction
model remains to be demonstrated for other structurally diverse
amyloidogenic proteins. Likewise, the representatives used in
this study (aSyn, Ab, htt, and PrP) do not share any charged
sequence similarity. Yet, the ability by which SERF1a managesstill detectable even at tR 48 hr, indicating that the conversion was not quantita
during aSyn amyloid fiber growth, indicating that itself does not aggregate or co
(C and D) Amyloid kinetics of 100 mM aSyn in the absence (closed blue circle) a
proteins TRAMDN (C) and hsp12 (D) (Ex/em slit widths = 10/20). Amyloidogenes
(E) Amyloid kinetics of GST-httQ53Ex1 in the absence (closed blue circle) and in t
proteolytic cleavage of the GST-tag (Wacker et al., 2004). Without cleavage of the
SERF1a; open green square in the presence of SERF1a). The weak signal increas
of amyloids.
(F) Amyloid kinetics of Ab40 in the absence (closed blue circle) and in the presen
(G) Amyloid kinetics of PrP in the absence (closed blue circle) and in the presenc
(H) Amyloid kinetics of 100 mM aSyn in the absence (closed black circle) and in
amounts of SERF1a are sufficient to enhance amyloidogenesis.
(I) A concentration of 1.5 mg/ml aSyn nucleation seeds, generated by ultrasonica
(1.5 mg/ml) (open red circle). The addition of 100 mM SERF1a marginally influenc
aSyn in the absence of seeds.
See also Figure S1. The error bars are mean averages, including SEM of three into collectively influence the early amyloid growth of these
proteins (i.e., by generally decreasing the lag time of amyloid
growth and by accelerating the half time of conversion, see Fig-
ure 2) leads to hypothesize the existence of mechanistically
related processes that remain to be addressed in detail.
The inactivity of SERF1a on nonamyloid aggregation is in
clear-cut contrast to general modifiers of protein aggregation,
such as molecular chaperones, the autophagy pathway or the
proteasome. This identifies SERF1as a specialized amyloid
factor and supports its autonomous mode of action observed
in cells (van Ham et al., 2010).
EXPERIMENTAL PROCEDURES
Unless otherwise specified, all reagents were from Sigma-Aldrich, Vienna,
Austria.
Protein Purification
Proteins were purified as described in the Extended Experimental Procedures.
NMR Spectroscopy
1H,15N-HSQC NMR titrations were carried out at 25C on a Bruker Avance III
(Bruker BioSpin, Karlsruhe, Germany) 700 MHz spectrometer equipped with
a CTI cryoprobe head. A uniformly labeled 15N-aSyn solution and an unlabeled
SERF1a solution were dialyzed overnight against 50mMbis-Tris, 20mMNaCl,
and 3 mM NaN3 (pH 6.8). A 40 mM
15N-aSyn solution was titrated with
increasing amounts of unlabeled SERF1a. Spectra were processed with
NMRPipe (Delaglio et al., 1995) and analyzed with NMRview (Johnson andtive. Lower (same samples; detection of SERF1a): SERF1a remained soluble
precipitate with amyloid fibers (see also Figure S1A).
nd in the presence (open green circle) of equimolar amyloid-unrelated control
is was insignificantly affected.
he presence of SERF1a (open green circle). Fiber formation was initiated by the
GST tag, amyloidogenesis did not occur (closed blue square in the absence of
e is possibly due to autoproteolysis and the resulting formation of little amounts
ce of SERF1a (open green square).
e of SERF1a (open green square).
the presence of different SERF1a ratios demonstrates that substoichiometric
tion of mature aSyn fibers, promotes the amyloid conversion of 100 mM aSyn
es seeded amyloidogenesis (open green square). (Closed blue circle) 100 mM
dependent experiments.
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Blevins, 1994) or Sparky (T. D. Goddard and D. G. Kneller, SPARKY 3, Univer-
sity of California, San Francisco). Previously assigned aSyn backbone
resonances were used (Falsone et al., 2009). Binding curves obtained from
chemical shift titrations were fitted to the equationDdobs =Ddmax
KD + ½SERF1a+ ½15N aSyn 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
KD + ½SERF1a+ ½15N aSyn2

 4½SERF1a½15N aSyn
r
2½15N aSyn ; (Equation 1)where Ddobs is the observed chemical shift perturbation, Ddmax is the maximal
chemical shift perturbation, and KD is the dissociation constant.
1H,15N-HSQC
spectra of 15N-SERF1a were acquired at 25C on a Varian Unity INOVA 600
MHzNMR spectrometer (Varian, Palo Alto, CA, USA) using anHCN triple-reso-
nance probe with single axis z-gradients. Data were processed using
NMRPipe (Delaglio et al., 1995) and analyzed in NMRView (Johnson and
Blevins, 1994). Data were collected using samples consisting of 100 mM
15N-labeled protein in 50 mM NaPi, 50 mM NaCl, and 3 mM NaN3 (pH 6.5).
10% D2O were added for field-frequency locking.
Fluorescence Anisotropy
The fluorescence anisotropy of a 100 nM Atto550-SERF1a preparation in
50 mM bis-Tris, 20 mM NaCl, and 3 mM NaN3 (pH 6.8) was measured at
25C on a LB50 spectrofluorimeter equipped with excitation and emission
polarisers (PerkinElmer, Waltham, MA, USA), at an emission wavelength of
576 nm upon excitation at 554 nm. Slit widths were 15 and 20 nm for excitation
and emission, respectively. The fluorescence anisotropy is defined as in
Lakowicz (1999):
r=
ðIVV  G x IVHÞ
ðIVV + 2G x IVHÞ; 0:4% r% 0:4; (Equation 2)
where IVV is the fluorescence intensity recorded with excitation and emission
polarizers in vertical positions, and IVH is the fluorescence intensity recorded
with the emission polarizer aligned in a horizontal position. The G factor is
the ratio of the sensitivities of the detection system for vertically and horizon-
tally polarized light G = IHV/IHH.
The Atto550-SERF1a solution was titrated against increasing amounts of
aSyn or aSyn1-110 diluted in the same buffer. For each point, the anisotropy
was recorded over 30 s and the mean r values for each measurement were
used. Anisotropy changes were fitted by using the Levenberg-Marquardt algo-
rithm to the equation (Falsone et al., 2009)Figure 3. SERF1a Does Not Affect Nonamyloid Protein Aggregation
(A) An excess of SERF1a (open green square) was unable to convert stable dopam
which is the mass equivalent of 50 mMmonomeric aSyn) into amyloid fibers. As a
blue circle) and in the presence (open green circle) of 50 mM SERF1a was measu
(B) TEM images show no morphological difference for ‘‘off-pathways’’ aggrega
bars = 100 nm.
(C) SERF1awas not able to disassemble ‘‘off-pathway’’ aggregates intomonomer
aliquots were drawn and analyzed by SDS-PAGE and immunoblotting (anti-aSy
over the whole experimental time range (20 days) despite the presence of SERF1
mixture of monomeric and oligomeric aSyn.
(D) SERF1a did not affect actin polymerization: the organized assembly of 10
a polymerization-induced fluorescence change in the absence (closed red square
open upward green triangle, and open downward brown triangle).
(E and F) SERF1a did not influence unspecific protein aggregation: an excess of SE
synthase (43C) (closed blue circle) or (F) reductive aggregation of insulin (closed
The lower graphs display changes in ThT fluorescence intensities for (D), (E
these reactions.
See also Figure S2. The error bars are mean averages, including SEM of three inKD+½SERF1a+½aSyn
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
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r
r=Drmax
2½SERF1a ;
(Equation 3)where r is the observed anisotropy, Drmax is the maximal anisotropy change,
and KD is the dissociation constant.
Circular Dichroism
SERF1a
Far-UV-circular dichroism spectra of 10 mMSERF1a in 20mMNaPi and 50mM
NaF (pH 7.0) were recorded at 25C on a J-715 spectropolarimeter (Jasco,
Tokyo, Japan) with a response time of 4 s and with a data point resolution of
0.2 nm using a 1 mm quartz cuvette. Three scans were averaged to obtain
smooth spectra.
aSyn
Far-UV-circular dichroism spectra of 10 mM aSyn or soluble aSyn aggregates
in 10 mM NaPi and 20 mM NaF (pH 7.4) were recorded at 25C on a J-715
spectropolarimeter (Jasco) with a response time of 4 s and with a data point
resolution of 0.2 nm using a 1 mm quartz cuvette. Three scans were averaged
to obtain smooth spectra.
Mean residue ellipticity calculations and secondary structure deconvolution
analysis were performed on the DICHROWEB platform (Whitmore and Wal-
lace, 2008) by applying the SELCON3 algorithm (Sreerama et al., 1999).
Dynamic Light Scattering
The Stokes radii of 5 mg/ml SERF1a or hen egg white lysozyme in 20 mM Tris
and 150 mM NaCl (pH 7.4) were determined using a DLS equipment
composed of a goniometer and a diode laser (Coherent Verdi V5, l =
532 nm, Pmax = 5 W) with single-mode fiber detection optics (OZ from GMP,
Zu¨rich, Switzerland), an ALV/SO-SIPD/DUAL photomultiplier with pseudo-
cross-correlation and an ALV 5000/E correlator with fast expansion (ALV,
Langen, Germany). Measurements were carried out at a scattering angle of
90. Correlation functions were collected for 60 s ten times and then averaged.
From these functions, the average diffusion coefficient D was obtained by
cumulant analysis (Koppel, 1972).
Samples of oligomeric aSyn in 20 mM Tris, 150 mM NaCl, and 3 mM NaN3
(pH 7.4) were measured on a DynaPro instrument (Protein Solutions,ine-induced ‘‘off-pathway’’ aSyn aggregates (closed blue square) (723 mg/ml,
control, the amyloid growth of 50 mMmonomeric aSyn in the absence (closed
red.
tes before (left) and after agitation in the presence of SERF1a (right). Scale
s: equimolar amounts of aggregates and SERF1a were incubated at 37C; 10 ml
n). SDS-resistant, high-molecular size aSyn oligomers were visible and stable
a, which did not cause their disruption into monomeric aSyn. Lane c = control
mM actin, covalently attached to the fluorophore pyrene, was monitored by
) and in the presence of increasing concentrations of SERF1a (open blue circle,
RF1a (open green square) did not affect (E) heat-induced aggregation of citrate
blue circle), as measured by changes of the solution’s turbidity.
), and (F), showing that ThT-reactive species did not accumulate during
dependent experiments.
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Figure 4. SERF1a Induces Transiently
Stable High Molecular Size aSyn Aggre-
gates
(A) Size-exclusion chromatograms of soluble
fractions of 150 mM aSyn, collected at different
time points after agitation at 37C, 1,400 rpm in the
presence (upper) and in the absence (lower) of
100 mMSERF1a. Centrifuged samples were run on
a Superdex 75 column, equilibrated with 50 mM
Tris and 150 mM NaCl (pH 7.4) at 1 ml/min flow
rate. SERF1a did not contribute to the absorbance
signal, due to the lack of aromatic residues, and it
was not present in the aggregate fraction (Fig-
ure S3C). Upper: SERF1a-induced aSyn aggre-
gates accumulated over time, in concomitance to
a decrease in monomeric aSyn, with a maximum
accumulation around 30–40 hr (red dotted curve).
After this time point, aggregates decreased in
parallel to monomeric aSyn, indicating their
consumption into unsoluble fibers (see also Fig-
ure 2B). Lower: In the absence of SERF1a, high
molecular size aggregates were virtually unde-
tectable, and the consumption of soluble mono-
meric aSyn was slower and less quantitative.
(B) The isolated aggregates acted as nucleation
templates for aSyn fibrils: seeding a 100 mM
(1.46 mg/ml) aSyn solution with different ratios of
these aggregates caused an acceleration of fiber
formation (closed black circle, open green square,
open upward blue triangle, and open downward
red triangle).
(C) Transmission electron micrograph of the iso-
lated aSyn intermediates display a morphology
consisting of small dots of 20–30 nm diameter and
short rods of varying length (50–400 nm). Scale
bars = 100 nm.
(D) Transmission electron micrographs of mature
aSyn amyloid fibers obtained in the absence (left)
and in the presence (middle) of SERF1a showed
no morphological difference. SERF1a alone did
not aggregate (right). Scale bars = 200 nm.
(E) Far-UV CD-spectrum of monomeric aSyn (solid
blue line) and of soluble aSyn aggregates (solid red
line). Although the spectrum of monomeric aSyn is
typically unstructured (lack of predominant alpha
helix or beta sheet signal, strong negative signal
around 200 nm, and a slow positive signal
recovery below 200 nm), the intermediate aggre-
gates are structured, as shown by a prominent
signal decrease around 215–220 nm and by
a positive signal increase below 200 nm.
Signal deconvolution analysis (Whitmore and
Wallace, 2008; Sreerama et al., 1999) yielded
9.9% alpha helix, 34.5% beta-sheet, and 56%
random coil for the aSyn aggregates versus 6.4%
alpha helix, 9.8% beta sheet, 82.9% random coil
for monomeric aSyn, attesting a predominant
structural rearrangement into beta-sheets. See
also Figure S3.Lakewood, NJ, USA) in a 1.5 mm pathlength 45 ml quartz cuvette at 25C.
Samples were centrifuged before measuring.
Small Angle Light Scattering
SAXS equipment comprised a SAXSess camera (Anton-Paar, Graz, Austria)
with high flux and low background, connected to an X-ray generator (Philips,
PW1730/10) operating at 40 kV and 50 mA with a sealed-tube Cu anode.366 Cell Reports 2, 358–371, August 30, 2012 ª2012 The AuthorsA Go¨bel mirror was used to convert the divergent polychromatic X-ray beam
into a focused line-shaped beam of Cu Ka radiation (wavelength l =
0.154 nm). The two-dimensional scattering pattern was recorded by a PI-
SCX-fused fiber optic taper CCD camera from Princeton Instruments (Trenton,
NJ, USA) and integrated into the one-dimensional scattering function I(q),
where q is the length of the scattering vector, defined by q = (4p/l)sin(q/2),
l being the wavelength and q being the scattering angle. The CCD
Figure 5. SERF1a Binds to the C-Terminal
Region of aSyn
(A) aSyn 1H,15N-HSQC-NMR perturbation dia-
gram showing chemical shift changes Dd after the
addition of SERF1a. The largest changes were
localized to the C-terminal region, between the
amino acids Gly111-Ala140 (red columns).
(B) Upper: Detail view of well-resolved and large
chemical shift changes that occur for amino acid
signals Asp122 and Ser129, upon titration with
SERF1a (arrows). Lower panels: The correspond-
ing binding curves yielded dissociation constants
KD = 7.59 ± 1.87 mM (Asp
122) and 9.81 ± 1.06 mM
(Ser129).
(C) Fluorescence anisotropy binding curves of
Atto550-SERF1a upon titration with aSyn (closed
blue circle; KD = 8.04 ± 2.09 mM) and aSyn1-110
(open green circle; nonsaturable binding, extrap-
olated KD > 1 mM). The interaction between
Atto550-SERF1a with aSyn was abolished by
increasing the ionic strength of the solution to
300 mM NaCl (closed upward black triangle),
pointing to a predominantly hydrophilic binding
mode.
(D) Amyloid fiber growth of the truncation mutant
aSyn1-110 was insensitive to SERF1a: amyloid
kinetics of aSyn1-110 in the absence (closed blue
circle) and in the presence (open green circle)
of SERF1a. Note that this truncation intrinsically
improves the amyloid properties of aSyn (tm =
7.70 ± 0.18 hr; tl = 6.56 ± 0.83 hr; kapp = 1.75 ±
0.17 hr; see also Hoyer et al., 2004 and Levitan
et al., 2011).
See also Figure S4. The error bars are mean
averages, including SEM of three independent
experiments.
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Figure 6. A Model for the Direct Amyloid-
Modifying Ability of SERF1a
As illustrated for the amyloidogenic-representa-
tive aSyn, SERF1a binds directly to this protein (A),
influencing early stages of amyloidogenesis (B).
By facilitating the transition between lag phase (C)
and elongation phase (D), the conversion of aSyn
monomers into amyloid fibers (E) becomes
improved, whereas nonamyloid aggregation
remains unaffected (F).detector used features a 2,084 3 2,084 array with 24 3 24 mm pixel size (chip
size: 50 3 50 mm). The CCD is operated at 30C with 10C water-assisted
cooling to reduce the thermally generated charge. Cosmic ray correction
and background subtraction were performed on the two-dimensional image
before further data processing. The temperature of the capillary and the
metallic sample holder was controlled by a Peltier element.
Transmission Electron Microscopy
A protein suspension was placed onto carbon-coated grids, blot dried, and
rinsed in distilled water for 1 min. Negative staining was performed by
applying1% uranylaceate for 1 min and blotting the liquid with filter paper.
Afterward the samples were air-dried and viewed with a Fei Tecnai 20 trans-
mission electron microscope (Fei, Hillsbro, OR, USA) operated at an acceler-
ation voltage of 120 kV. Images were recorded on a Gatan US1000 digital
camera (Gatan, Pleasanton, CA, USA).
Kinetics of Amyloid Fiber Growth
General Settings
All ThT fluorescence measurements were done in triplicate on a Cary Eclipse
fluorescence spectrometer (Agilent, Santa Clara, CA, USA) at 25C and
482 nm upon excitation at 442 nm. Unless otherwise described, the photomul-
tiplier voltage was 600 V. The slit widths were set as specified separately. The
pH was controlled at the beginning and at the end of each reaction to exclude
artificial fiber growth effects. Except for htt, a manual discontinuous setup was
used for all measurements. As a standard procedure, all buffers were filtered
through a 0.45 mm filter membrane, and all samples were centrifuged
(13,000 g; 15 min; 4C) before use.
The amyloid growth curves were fitted by using the Levenberg-Marquardt
algorithm to the equation (Uversky et al., 2001)
F=

Fi +m

i t

+

Ff +m

f t

ð1+ eððtmtÞkappÞÞ
; (Equation 4)
where Fi is the initial fluorescence value, Ff is the final fluorescence value, tm is
themidpoint of amyloid conversion, andmi andmf are correction values for the
lag phase and the postgrowth fluorescence. The initial lag time tl corresponds
to tm - 2/kapp, where kapp is the apparent rate constant for amyloid growth.
The values are mean averages, including SEM of three independent
measurements.368 Cell Reports 2, 358–371, August 30, 2012 ª2012 The AuthorsaSyn; aSyn1-110
Lyophilized protein was reconstituted in 50 mM
TrisHCl, 150 mM NaCl, and 3 mM NaN3 (pH 7.4)
(aSyn-working buffer) to a concentration of
approximately 1 mM. A preparative gel filtration
chromatography step (self-packed Superdex 75
column [GE Healthcare, Uppsala, Sweden];
500 ml bed volume; flow rate 2 ml/min; elution
buffer = aSyn-working buffer) was run to remove
possible aggregates and degradation products
that might artificially influence amyloid growth
kinetics. The fractions corresponding to mono-
meric protein were pooled and concentrated inan Amicon Ultra-15 centrifugal filter unit with a 3 kDa cutoff (Merck Millipore,
Billerica, MA, USA). Unless otherwise described, this solution was adjusted
to 200 mM with aSyn-working buffer. An additional gel filtration chromatog-
raphy analysis (Superdex 75 10/300; GE-Healthcare; flow rate 0.7 ml/min)
was performed to confirm that aSyn was still homogenous and monomeric
after the concentration procedure. A 100 ml volume of this same solution
was mixed in a clean 1.5 ml Eppendorf plastic vial with 100 ml of a 200 mM
SERF1a solution previously dialyzed against aSyn-working buffer, or with
100 ml working buffer alone, to a final volume of 200 ml. The vials were sealed
with Parafilm, taped to the rack of an Eppendorf thermomixer 5436 (Eppen-
dorf, Hamburg, Germany) to prevent their rotation during agitation, and shaken
at 1,400 rpm, 37C. Aliquots of 5 ml were taken at the indicated time points and
diluted into 1 ml of a 5 mM ThT solution freshly prepared in aSyn-working
buffer, and the ThT fluorescence of the samples wasmeasured in a 1ml quartz
cuvette at room temperature. Ex/em slit widths = 10/10 nm.
GST-httQ53Ex1
Monomeric htt protein was freshly purified as described in Extended Experi-
mental Procedures and used immediately. In a clean 1 ml quartz cuvette,
100 ml of a freshly prepared 120 mM htt solution in 50 mM Tris-HCl, 150 mM
NaCl, and 1 mM DTT (pH 7.0) (htt-working buffer) was mixed with 100 ml of
a 120 mM SERF1a solution that had been previously dialyzed against htt-
working buffer, or with 100 ml htt-working buffer, to a volume of 200 ml. To
this solution, 800 ml of a 5 mM ThT solution freshly prepared in htt-working
buffer was added to a final volume of 1 ml. The cuvette was placed into a pre-
heated (37C) sample cell holder of a fluorescence spectrometer, and amyloid
growth was initiated in situ by cleaving the GST tag with 10 ml PreScission
protease (500 u; Invitrogen, Carlsbad, CA, USA). The cuvette was capped,
and ThT fluorescence was measured with a continuous setup at 37C without
agitation, with a time step resolution of 2 min, and compared to uncleaved
controls. Ex/em slit widths = 20/20 nm.
Ab40
Lyophilized Ab40 peptide was dissolved in hexafluoroisopropanol (HFIP;
Fluka) to a concentration of 2 mg/ml, divided into 250 mg aliquots in 1.5 ml
Eppendorf plastic vials, and HFIP was evaporated on a vacuum centrifuge.
One aliquot was reconstituted in 250 ml milliQ H2O, dissolved by sonication
for 10 min in an ice-cooled ultrasound water bath, centrifuged (13,000 rpm,
10min), and the concentration of the supernatant wasmeasured on a spectro-
photometer at 214 nm absorbance wavelength (ε = 55,771 M1 cm1).
In a clean 1.5ml Eppendorf plastic vial, 100 ml of a 200 mMAm40 solution was
prepared in H2O and adjusted to 13 PBS / 3 mM NaN3 (Ab-working buffer) by
the addition of 103 PBS. To this solution, 100 ml of a 200 mM SERF1a solution
prepared in Ab-working buffer, or 100 ml Ab-working buffer alone was added to
a final volume of 200 ml. The plastic vials were sealed with Parafilm, taped to
the rack of an Eppendorf thermomixer 5436 (Eppendorf), and agitated at
37C and 300 rpm. Aliquots of 10 ml were taken at the indicated time points,
diluted into 100 ml of a 20 mM ThT solution freshly prepared in Ab-working
buffer, and incubated for 5 min, and the fluorescence of the sample was
measured in a 150 ml quartz cuvette at room temperature, with a photomulti-
plier setting of 650 V. Ex/em slit widths = 5/5 nm.
PrP
Amyloid fiber growth of mouse full-length Prp was measured by an adaptation
of Breydo et al. (2008), undermild denaturing conditions and slightly acidic pH.
These conditions did not compromise the amyloid-promoting effect of
SERF1a (Figure 2G). A 136 mM PrP stock solution in 6 M GdnHCl (pH 6.0)
was freshly prepared and used immediately. To prepare 200 ml of a 20 mM
PrP reaction solution, 29.41 ml of the PrP stock solution was diluted in a clean
1.5 ml Eppendorf plastic vial with 109.32 ml H2O, 33.36 ml 6 MGdnHCl (pH 6.0),
20 ml 0.5 M MES (pH 6.0), and 3 mM NaN3. To this solution, 10 ml of 800 mM
SERF1a prepared in 0.5 M MES (pH 6.0) and 3 mM NaN3 was added to a final
concentration of 40 mM. No nucleation seeds were added. The plastic vials
were sealed with Parafilm, taped to the rack of an Eppendorf thermomixer
5436 (Eppendorf), and agitated at 37C and 1,000 rpm. Aliquots of 10 ml
were taken at the indicated time points, diluted into 1 ml of a 10 mM ThT solu-
tion freshly prepared in 10 mM Na-acetate (pH 5.0), and measured in a 1 ml
quartz cuvette at room temperature. Ex/em slit widths = 10/20 nm.
Partition Analysis
A 500 ml volume of a 200 mM aSyn solution in 50 mM TrisHCl, 150 mM NaCl,
and 3 mM NaN3 (pH 7.4) were mixed with 500 ml of a 200 mM SERF1a solution
in the same buffer, or with 500 ml buffer alone, sealed with Parafilm, taped to
the rack of an Eppendorf thermomixer 5436 (Eppendorf), and agitated at
37C and 1,400 rpm. After given time points, 50 ml samples were taken and
frozen immediately at 20C. Each sample was then centrifuged at 20,000 g,
the unsoluble fraction was washed twice, and resuspended in 50 ml of
50 mM TrisHCl, 150 mM NaCl, and 3 mM NaN3 (pH 7.4). For soluble and
unsoluble samples, 10 ml were used for dot-blotting, and 5 ml for PAGE-elec-
trophoresis (see ‘‘Immunoblotting’’ section).
Immunoblotting
For dot-blotting, samples were directly applied onto a Hybond ECL nitrocellu-
lose membrane (GE Lifesciencs) by using a Bio-Dot microfiltration apparatus
(BioRad, Hercules, CA, USA) as specified by the manufacturer. In brief,
samples were applied into slots presoaked with TBS, allowed to adsorb
onto the membrane, and washed twice with TBST.
For electroblotting, samples were run on a SDS-PAGE gel (12% NuPAGE,
Invitrogen) or an 8% native-PAGE gel (Tris [pH 7.6]) and transferred on a nitro-
cellulose membrane.
Membranes from dot-blots or gel electrotransfer were incubated 1 hr (room
temperature) to overnight (4C) in 5% skim milk/TBST, 3 mM NaN3, and
shaken for 2 hr at room temperature with the respective primary antibody
diluted in 1% skim milk/TBST, 3 mM NaN3 (1:2,000 anti-aSyn [produced in-
house] and 1:200 anti-SERF1, K-13 clone [Santa Cruz Biotech, Santa Cruz,
CA, USA]), and 1.30 hr with secondary antibody in 1% skim milk/TBST,
3 mM NaN3 (1:2,000 goat anti-rabbit (Santa Cruz Biotech) for aSyn and
1:1,000 mouse anti-goat [Santa Cruz Biotech] for SERF1a). The blots were
then incubated with ECL reagent (Santa Cruz Biotech) and developed on a
Kodak X-OMATIC film.
Actin Polymerization Assay
Actin polymerization was measured with a commercial assay (Cytoskeleton,
Denver, CO, USA), by an adaptation of the manufacturer’s instructions. The
assay detects the fluorescence enhancement of pyrene-labeled G-actin
during the conversion into polymeric F-actin. A 300 ml volume of a 10 mM actin
solution in 5 mM Tris, 0.2 mMCaCl, 0.2 mM ATP, and 1 mMDTT (pH 8.0) were
incubated for 1 hr and centrifuged. After baseline equilibration, the polymeriza-
tion was induced by the addition of 30 ml polymerization buffer (500 mM KCl,
20 mM MgCl2, and 10 mM ATP) alone, or by the same volume of a SERF1asolution in polymerization buffer. The fluorescence was recorded on a Cary
Eclipse fluorescence spectrometer at 25C and 405 nm upon excitation at
360 nm. Ex/em slit = 2.5/5 nm.
The same measurements were repeated in the presence of 5 mM ThT, at
ex/em wavelength 442/482 nm.
Citrate Synthase Aggregation Assay
A stock solution of citrate synthase from porcine heart was prepared as in
Buchner et al. (1998). Citrate synthase was added to 40 mM HEPES-KOH
(pH 7.5) preincubated at 43C to a final concentration of 150 nM, in the
absence of in the presence of SERF1a dissolved in the same reaction buffer.
The aggregation was measured on a Cary Eclipse fluorescence spectrometer
as an increase in turbidity, with excitation and emission wavelength both at
360 nm. Ex/em slit widths = 5/5 nm.
The same measurements were repeated in the presence of 5 mM ThT, at ex/
em 442/482 nm wavelength.
Insulin Aggregation Assay
A 10 mg/ml human insulin stock solution was prepared in H20 by the dropwise
addition of concentrated HCl until the dissolution was complete. A 30 mM
insulin solution in 100 mM NaPi and 100 mM NaCl (pH 7.4) were incubated
at 37C, and aggregation was initiated by the addition of DTT to a final concen-
tration of 20 mM (Scheibel et al., 1998) in the absence and in the presence of
SERF1a. The turbidity was measured on a Cary Eclipse fluorescence spec-
trometer. Ex/em wavelengths were both 650 nm, low photomultiplier sensi-
tivity. Ex/em slit widths = 2.5/5 nm.
The same measurements were repeated in the presence of 5 mM ThT, at ex/
em 442/482 nm wavelength.
Isolation of Dopamine-Induced aSyn ‘‘Off-Pathway’’ Aggregates
Stable, SDS-resistant oligomers were produced by an adaptation of Cappai
et al. (2005). A 300 mM aSyn solution in 50 mM Tris HCl, 150 mM NaCl, and
3 mM NaN3 (pH 7.4) were agitated with 5 mM dopamine in a 0.5 ml reaction
volume for 72 hr at 37C, 1,400 rpm. Unsoluble material was removed by
centrifugation, and the oligomers were purified on a Superdex75 (GE Life
Sciences, Uppsala, Sweden) column (self-packed XK16/100, 180 ml bed
volume), at a flow rate of 1 ml/min, and a 1 ml sample collection volume. Olig-
omer-containing fractions were pooled and concentrated. The concentration
of the oligomers was measured by the BCA assay. Monomeric, preweighed
aSyn was used to generate the calibration curve. The final concentrations
were kept around 3.5–4 mg/ml oligomeric aSyn.
Isolation of SERF-Induced Amyloid Intermediates
A 1 ml volume of a solution consisting of 150 mM aSyn and 100 mM SERF1a in
50 mM Tris, 150 mMNaCl, and 3 mMNaN3 (pH 7.4) was agitated at 1,400 rpm
for 30–40 hr at 37C. Longer agitation was avoided because of the decrease in
the amount of soluble aggregates. Unsoluble material was separated by
centrifugation, and the clear solutionwas immediately loaded on aSuperdex75
(GE Life Sciences) gel filtration column (self-packed XK16/100, 180 ml bed
volume), with a flow rate of 1 ml/min and a 1 ml sample collection volume.
Chromatograms were recorded at an absorbance wavelength of 280 nm. At
this wavelength, SERF1a was not visible because of the lack of aromatic resi-
dues and thus did not contribute to the chromatographic signal. Fractions
containing aggregates eluted in the void volume. They were pooled and
concentrated to 600–700 mg/ml. The concentration of the oligomers was
measured by the BCA assay (Thermo Scientific, Rockford, IL, USA), using
a calibration curve generated with monomeric, preweighed aSyn.
The freshly prepared oligomers were stored at 4C and were used immedi-
ately for further studies. The preparations were stable for approximately
2 days.
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